{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:05:26Z","timestamp":1784070326125,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["CO-US-276-5866"],"award-info":[{"award-number":["CO-US-276-5866"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13384-6","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:05:46Z","timestamp":1779332746000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The safety and tolerability of oral TDF\/FTC as pre-exposure prophylaxis among men who have sex with men in China: a prospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3561-2804","authenticated-orcid":false,"given":"Jie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniruddha","family":"Hazra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renslow","family":"Sherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"13384_CR1","unstructured":"Global HIV. & AIDS statistics \u2014 Fact sheet | UNAIDS. https:\/\/www.unaids.org\/en\/resources\/fact-sheet. Accessed 9 Dec 2025."},{"key":"13384_CR2","doi-asserted-by":"publisher","unstructured":"National HIV, STI epidemic situation in December. 2023. Chin J AIDS STD. 2024;30:225. https:\/\/doi.org\/10.13419\/j.cnki.aids.2024.03.01.","DOI":"10.13419\/j.cnki.aids.2024.03.01"},{"key":"13384_CR3","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.16462\/j.cnki.zhjbkz.2021.12.001","volume":"25","author":"Na He","year":"2021","unstructured":"Na He. New progress of AIDS epidemiology in China. Chin J Dis Control Prev. 2021;25:1365\u20138. https:\/\/doi.org\/10.16462\/j.cnki.zhjbkz.2021.12.001.","journal-title":"Chin J Dis Control Prev"},{"key":"13384_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.13419\/j.cnki.aids.2023.09.02","volume":"29","author":"Chinese Association of STD and AIDS Prevention and Control, HIV Pre-Exposure Prophylaxis Expert Consensus Committee","year":"2023","unstructured":"Chinese Association of STD and AIDS Prevention and Control, HIV Pre-Exposure Prophylaxis Expert Consensus Committee. Expert Consensus on HIV Pre-Exposure Prophylaxis in China. Chin J AIDS STD. 2023;29:954\u201361. https:\/\/doi.org\/10.13419\/j.cnki.aids.2023.09.02.","journal-title":"Chin J AIDS STD"},{"key":"13384_CR5","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1016\/S2468-2667(21)00112-2","volume":"6","author":"BR Bavinton","year":"2021","unstructured":"Bavinton BR, Grulich AE. HIV pre-exposure prophylaxis: scaling up for impact now and in the future. Lancet Public Health. 2021;6:e528\u201333. https:\/\/doi.org\/10.1016\/S2468-2667(21)00112-2.","journal-title":"Lancet Public Health"},{"key":"13384_CR6","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1016\/S2352-3018(18)30215-7","volume":"5","author":"AE Grulich","year":"2018","unstructured":"Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5:e629\u201337. https:\/\/doi.org\/10.1016\/S2352-3018(18)30215-7.","journal-title":"Lancet HIV"},{"key":"13384_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10461-018-2205-3","volume":"23","author":"L Zhang","year":"2019","unstructured":"Zhang L, Peng P, Wu Y, Ma X, Soe NN, Huang X, et al. Modelling the Epidemiological Impact and Cost-Effectiveness of PrEP for HIV Transmission in MSM in China. AIDS Behav. 2019;23:523\u201333. https:\/\/doi.org\/10.1007\/s10461-018-2205-3.","journal-title":"AIDS Behav"},{"key":"13384_CR8","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1016\/S2352-3018(19)30293-0","volume":"7","author":"J Xu","year":"2020","unstructured":"Xu J, Tang W, Zhang F, Shang H. PrEP in China: choices are ahead. Lancet HIV. 2020;7:e155\u20137. https:\/\/doi.org\/10.1016\/S2352-3018(19)30293-0.","journal-title":"Lancet HIV"},{"key":"13384_CR9","doi-asserted-by":"publisher","first-page":"e1636","DOI":"10.1016\/S2214-109X(25)00234-7","volume":"13","author":"H Jiang","year":"2025","unstructured":"Jiang H, Zou H. PrEParing for HIV prevention among men who have sex with men in China: challenges and solutions. Lancet Global Health. 2025;13:e1636\u201341. https:\/\/doi.org\/10.1016\/S2214-109X(25)00234-7.","journal-title":"Lancet Global Health"},{"key":"13384_CR10","doi-asserted-by":"publisher","first-page":"e055899","DOI":"10.1136\/bmjopen-2021-055899","volume":"12","author":"C Li","year":"2022","unstructured":"Li C, Xiong Y, Muessig KE, Tang W, Huang H, Mu T, et al. Community-engaged mHealth intervention to increase uptake of HIV pre-exposure prophylaxis (PrEP) among gay, bisexual and other men who have sex with men in China: study protocol for a pilot randomised controlled trial. BMJ Open. 2022;12:e055899. https:\/\/doi.org\/10.1136\/bmjopen-2021-055899.","journal-title":"BMJ Open"},{"key":"13384_CR11","unstructured":"Smith D. (CDC\/DDID\/NCHHSTP\/DHP). Preexposure prophylaxis. 2021."},{"key":"13384_CR12","unstructured":"Consolidated guidelines on the use of antiretroviral drugs for treating. and preventing HIV infection: recommendations for a public health approach, 2nd ed. https:\/\/www.who.int\/publications-detail-redirect\/9789241549684. Accessed 3 Jan 2024."},{"key":"13384_CR13","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","volume":"373","author":"J-M Molina","year":"2015","unstructured":"Molina J-M, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 2015;373:2237\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1506273.","journal-title":"N Engl J Med"},{"key":"13384_CR14","unstructured":"Common Terminology. Criteria for Adverse Events (CTCAE). 2017."},{"key":"13384_CR15","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1016\/S2352-3018(22)00133-3","volume":"9","author":"J-M Molina","year":"2022","unstructured":"Molina J-M, Ghosn J, Assoumou L, Delaugerre C, Algarte-Genin M, Pialoux G, et al. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study. Lancet HIV. 2022;9:e554\u201362. https:\/\/doi.org\/10.1016\/S2352-3018(22)00133-3.","journal-title":"Lancet HIV"},{"key":"13384_CR16","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. N Engl J Med. 2010;363:2587\u201399. https:\/\/doi.org\/10.1056\/NEJMoa1011205.","journal-title":"N Engl J Med"},{"key":"13384_CR17","doi-asserted-by":"publisher","first-page":"e2148782","DOI":"10.1001\/jamanetworkopen.2021.48782","volume":"5","author":"H Wang","year":"2022","unstructured":"Wang H, Wang Z, Huang X, Chen Y, Wang H, Cui S, et al. Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China. JAMA Netw Open. 2022;5:e2148782. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.48782.","journal-title":"JAMA Netw Open"},{"key":"13384_CR18","doi-asserted-by":"publisher","first-page":"e25795","DOI":"10.1002\/jia2.25795","volume":"24","author":"TH Kwan","year":"2021","unstructured":"Kwan TH, Lui GCY, Lam TTN, Lee KCK, Wong NS, Chan DPC, et al. Comparison between daily and on-demand PrEP (pre\u2010exposure prophylaxis) regimen in covering condomless anal intercourse for men who have sex with men in Hong Kong: A randomized, controlled, open\u2010label, crossover trial. J Int AIDS Soc. 2021;24:e25795. https:\/\/doi.org\/10.1002\/jia2.25795.","journal-title":"J Int AIDS Soc"},{"key":"13384_CR19","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.jadohealth.2023.09.005","volume":"73","author":"I Dourado","year":"2023","unstructured":"Dourado I, Soares F, Magno L, Amorim L, Eustorgio Filho M, Leite B, et al. Adherence, Safety, and Feasibility of HIV Pre-Exposure Prophylaxis Among Adolescent Men Who Have Sex With Men and Transgender Women in Brazil (PrEP1519 Study). J Adolesc Health. 2023;73:S33\u201342. https:\/\/doi.org\/10.1016\/j.jadohealth.2023.09.005.","journal-title":"J Adolesc Health"},{"key":"13384_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12981-022-00437-4","volume":"19","author":"KCS Petruccelli","year":"2022","unstructured":"Petruccelli KCS, Ba\u00eda-da-Silva DC, Val F, Val\u00f5es MS, Cubas-Vega N, Silva-Neto AV, et al. Kidney function and daily emtricitabine\/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil. AIDS Res Ther. 2022;19:12. https:\/\/doi.org\/10.1186\/s12981-022-00437-4.","journal-title":"AIDS Res Ther"},{"key":"13384_CR21","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/cid\/ciw022","volume":"62","author":"DV Glidden","year":"2016","unstructured":"Glidden DV, Amico KR, Liu AY, Hosek SG, Anderson PL, Buchbinder SP, et al. Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension. Clin Infect Dis. 2016;62:1172\u20137. https:\/\/doi.org\/10.1093\/cid\/ciw022.","journal-title":"Clin Infect Dis"},{"key":"13384_CR22","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.2147\/DDDT.S274307","volume":"14","author":"N Squillace","year":"2020","unstructured":"Squillace N, Ricci E, Menzaghi B, De Socio GV, Passerini S, Martinelli C, et al. The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile. DDDT. 2020;14:5515\u201320. https:\/\/doi.org\/10.2147\/DDDT.S274307.","journal-title":"DDDT"},{"key":"13384_CR23","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s11606-020-05651-2","volume":"35","author":"P Saberi","year":"2020","unstructured":"Saberi P, Scott HM. On-Demand Oral Pre-exposure Prophylaxis with Tenofovir\/Emtricitabine: What Every Clinician Needs to Know. J GEN INTERN MED. 2020;35:1285\u20138. https:\/\/doi.org\/10.1007\/s11606-020-05651-2.","journal-title":"J GEN INTERN MED"},{"key":"13384_CR24","doi-asserted-by":"publisher","first-page":"101776","DOI":"10.1016\/j.eclinm.2022.101776","volume":"56","author":"SE Stansfield","year":"2023","unstructured":"Stansfield SE, Moore M, Boily M-C, Hughes JP, Donnell DJ, Dimitrov DT. Estimating benefits of using on-demand oral prep by MSM: a comparative modeling study of the US and Thailand. eClinicalMedicine. 2023;56:101776. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101776.","journal-title":"eClinicalMedicine"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13384-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13384-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13384-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:17:14Z","timestamp":1784067434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13384-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13384"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13384-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reviewed and approved by the Institutional Review Boards at the University of Chicago, USA (IRB#20-1388), the Guangzhou Eighth People\u2019s Hospital, China (IRB#202043176), and the Zhongnan Hospital of Wuhan University, China (IRB#2021082). All participants provided written informed consent before enrollment. The study was performed in accordance with the guidelines of the Declaration of Helsinki and relevant regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1336"}}